Holen Sie sich die Stockscreener-App
4.60
1.10%
0.05
Schlusskurs vom Vortag:
$4.55
Offen:
$4.55
24-Stunden-Volumen:
17,794
Relative Volume:
0.30
Marktkapitalisierung:
$195.77M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-46.77M
KGV:
-2.7394
EPS:
-1.6792
Netto-Cashflow:
$-60.34M
1W Leistung:
-8.00%
1M Leistung:
-19.72%
6M Leistung:
-42.86%
1J Leistung:
-44.44%
1-Tages-Spanne:
$4.5006
$4.658
1-Wochen-Bereich:
$4.41
$4.825
52-Wochen-Spanne:
$4.345
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Vergleichen Sie NYXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
4.60 | 195.77M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
562.37 | 195.76B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.96 | 54.34B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
76.71 | 36.86B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.07 | 35.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
269.20 | 18.54B | 2.96B | 487.70M | 344.00M | 6.6758 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Will Nyxoah SA (5YI) stock extend growth storyCPI Data & Accurate Technical Buy Alerts - newser.com
Can Nyxoah SA stock sustain free cash flow growth2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
Why Nyxoah SA (5YI) stock attracts wealthy investorsIndex Update & Consistent Growth Equity Picks - newser.com
Information on the total number of voting rights and shares - GlobeNewswire
Why Nyxoah SA stock is seen as undervaluedJuly 2025 Decliners & Low Drawdown Investment Strategies - newser.com
Can Nyxoah SA stock sustain market leadershipJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
Should I buy Nyxoah SA (5YI) stock before earnings seasonWeekly Risk Report & Daily Chart Pattern Signals - newser.com
How Nyxoah SA (5YI) stock trades under stagflation2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
How Nyxoah SA (5YI) stock compares with market leaders2025 Support & Resistance & Momentum Based Trading Signals - newser.com
How high can Nyxoah SA stock go2025 Dividend Review & Weekly Setup with ROI Potential - newser.com
How Nyxoah SA (5YI) stock compares with tech leadersWeekly Trade Report & Fast Gaining Stock Reports - newser.com
Heatmap analysis for Nyxoah SA and competitorsJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Latham DQ'd From Sleep Apnea Device Co.'s Patent Fight - Law360
How Nyxoah SA (5YI) stock trades pre earningsJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
Can Nyxoah SA (5YI) stock double in coming yearsMarket Rally & Weekly Top Stock Performers List - newser.com
Latham & Watkins Disqualified in Inspire IP Suit Against Nyxoah - news.bloomberglaw.com
Will Nyxoah SA stock deliver strong dividend growthJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
Using Ichimoku Cloud for Nyxoah SA technicals2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Will Nyxoah SA (5YI) stock recover faster than industry2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Why Nyxoah SA stock could see breakout soonJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - newser.com
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):